| Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer MCF Cysouw, BHE Jansen, T van de Brug, DE Oprea-Lager, E Pfaehler, ... European journal of nuclear medicine and molecular imaging 48, 340-349, 2021 | 106 | 2021 |
| Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis MCF Cysouw, GM Kramer, LJ Schoonmade, R Boellaard, HCW de Vet, ... European journal of nuclear medicine and molecular imaging 44, 2105-2116, 2017 | 52 | 2017 |
| Simplified methods for quantification of 18F-DCFPyL uptake in patients with prostate cancer BHE Jansen, M Yaqub, J Voortman, MCF Cysouw, AD Windhorst, ... Journal of nuclear medicine 60 (12), 1730-1735, 2019 | 45 | 2019 |
| Benefits of using stereotactic body radiotherapy in patients with metachronous oligometastases of hormone-sensitive prostate cancer detected by [18F] fluoromethylcholine PET/CT EW Bouman-Wammes, JM van Dodewaard-De Jong, M Dahele, ... Clinical genitourinary cancer 15 (5), e773-e782, 2017 | 44 | 2017 |
| Healthy tissue uptake of 68Ga-prostate-specific membrane antigen, 18F-DCFPyL, 18F-fluoromethylcholine, and 18F-dihydrotestosterone BHE Jansen, GM Kramer, MCF Cysouw, MM Yaqub, B de Keizer, ... Journal of Nuclear Medicine 60 (8), 1111-1117, 2019 | 33 | 2019 |
| Accuracy and precision of partial-volume correction in oncological PET/CT studies MCF Cysouw, GM Kramer, OS Hoekstra, V Frings, AJ de Langen, EF Smit, ... Journal of Nuclear Medicine 57 (10), 1642-1649, 2016 | 33 | 2016 |
| Repeatability of quantitative 18F-DCFPyL PET/CT measurements in metastatic prostate cancer BHE Jansen, MCF Cysouw, AN Vis, RJA van Moorselaar, J Voortman, ... Journal of Nuclear Medicine 61 (9), 1320-1325, 2020 | 31 | 2020 |
| Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features JJ Eertink, GJC Zwezerijnen, MCF Cysouw, SE Wiegers, EAG Pfaehler, ... European journal of nuclear medicine and molecular imaging 49 (13), 4642-4651, 2022 | 24 | 2022 |
| Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer WI Luining, MCF Cysouw, D Meijer, NH Hendrikse, R Boellaard, AN Vis, ... Cancers 14 (5), 1169, 2022 | 24 | 2022 |
| Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics MCF Cysouw, SVS Golla, V Frings, EF Smit, OS Hoekstra, GM Kramer, ... EJNMMI research 9, 1-11, 2019 | 23 | 2019 |
| Bone metastases are measurable: the role of whole-body MRI and positron emission tomography DE Oprea-Lager, MCF Cysouw, R Boellaard, CM Deroose, ... Frontiers in oncology 11, 772530, 2021 | 22 | 2021 |
| Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network BM de Vries, SSV Golla, J Ebenau, SCJ Verfaillie, T Timmers, F Heeman, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 721-728, 2021 | 17 | 2021 |
| Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer MCF Cysouw, GM Kramer, D Heijtel, RC Schuit, MJ Morris, ... EJNMMI research 9, 1-12, 2019 | 13 | 2019 |
| Prognostic value of [18F]-fluoromethylcholine positron emission tomography/computed tomography before stereotactic body radiation therapy for oligometastatic prostate cancer M Cysouw, E Bouman-Wammes, O Hoekstra, A van den Eertwegh, M Piet, ... International Journal of Radiation Oncology* Biology* Physics 101 (2), 406-410, 2018 | 13 | 2018 |
| Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake MCF Cysouw, BHE Jansen, M Yaqub, J Voortman, AN Vis, ... Molecular Imaging and Biology 22, 15-17, 2020 | 11 | 2020 |
| Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images MCF Cysouw, GM Kramer, V Frings, AJ De Langen, MJ Wondergem, ... Nuclear medicine and biology 51, 18-24, 2017 | 6 | 2017 |
| Reply: Quantification of 18F-DCFPyL uptake: TBR versus Patlak’s analysis BHE Jansen, M Yaqub, MCF Cysouw, AN Vis, RJA van Moorselaar, ... Journal of Nuclear Medicine 60 (12), 1834-1835, 2019 | 3 | 2019 |
| SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden YJL Bodar, BPF Koene, BHE Jansen, MCF Cysouw, D Meijer, ... Journal of Nuclear Medicine 62 (9), 1264-1269, 2021 | 2 | 2021 |
| A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients … WI Luining, LMS Boevé, MJ Hagens, D Meijer, T de Weijer, RH Ettema, ... European Urology Oncology, 2024 | | 2024 |
| The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach CFM van Hooijdonk, M van der Pluijm, BM de Vries, M Cysouw, ... Schizophrenia Research 262, 132-141, 2023 | | 2023 |
Ronald BoellaardProfessor Clinical Physics of Positron Emission Tomography, VUmc, AmsterdamGeverifieerd e-mailadres voor vumc.nl
